
### [NCIT:C7898](http://purl.obolibrary.org/obo/NCIT_C7898)
**Label:** Stage III Bladder Cancer

**Subclasses:** [NCIT:C8905](http://purl.obolibrary.org/obo/NCIT_C8905) (Stage III Bladder Squamous Cell Carcinoma), [NCIT:C8940](http://purl.obolibrary.org/obo/NCIT_C8940) (Stage III Bladder Urothelial Carcinoma), [NCIT:C8897](http://purl.obolibrary.org/obo/NCIT_C8897) (Stage III Bladder Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C27970](http://purl.obolibrary.org/obo/NCIT_C27970) (Stage III) 54.17%
- Thing 52.77%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40295](http://purl.obolibrary.org/obo/NCIT_C40295) (Bartholin Gland Adenoid Cystic Carcinoma))) 39.52%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40293](http://purl.obolibrary.org/obo/NCIT_C40293) (Bartholin Gland Squamous Cell Carcinoma))) 39.52%


